These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28916223)

  • 1. BET-bromodomain inhibitors modulate epigenetic patterns at the diacylglycerol kinase alpha enhancer associated with radiation-induced fibrosis.
    Valinciute G; Weigel C; Veldwijk MR; Oakes CC; Herskind C; Wenz F; Plass C; Schmezer P; Popanda O
    Radiother Oncol; 2017 Oct; 125(1):168-174. PubMed ID: 28916223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation of diacylglycerol kinase alpha promotes radiation-induced fibrosis.
    Weigel C; Veldwijk MR; Oakes CC; Seibold P; Slynko A; Liesenfeld DB; Rabionet M; Hanke SA; Wenz F; Sperk E; Benner A; Rösli C; Sandhoff R; Assenov Y; Plass C; Herskind C; Chang-Claude J; Schmezer P; Popanda O
    Nat Commun; 2016 Mar; 7():10893. PubMed ID: 26964756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Modulation of Radiation-Induced Diacylglycerol Kinase Alpha Expression Prevents Pro-Fibrotic Fibroblast Response.
    Liu CS; Toth R; Bakr A; Goyal A; Islam MS; Breuer K; Mayakonda A; Lin YY; Stepper P; Jurkowski TP; Veldwijk MR; Sperk E; Herskind C; Lutsik P; Weichenhan D; Plass C; Schmezer P; Popanda O
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34070078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibitors of bromodomain BD1 and BD2 of BET proteins modulate radiation-induced profibrotic fibroblast responses.
    Liu CS; Rioja I; Bakr A; Veldwijk MR; Sperk E; Herskind C; Weichenhan D; Prinjha RK; Plass C; Schmezer P; Popanda O
    Int J Cancer; 2022 Jul; 151(2):275-286. PubMed ID: 35239184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
    Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
    Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological targeting of BET proteins attenuates radiation-induced lung fibrosis.
    Wang J; Zhou F; Li Z; Mei H; Wang Y; Ma H; Shi L; Huang A; Zhang T; Lin Z; Wu G
    Sci Rep; 2018 Jan; 8(1):998. PubMed ID: 29343723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
    Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
    Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BET bromodomain proteins regulate transcriptional reprogramming in genetic dilated cardiomyopathy.
    Antolic A; Wakimoto H; Jiao Z; Gorham JM; DePalma SR; Lemieux ME; Conner DA; Lee DY; Qi J; Seidman JG; Bradner JE; Brown JD; Haldar SM; Seidman CE; Burke MA
    JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32603312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic blockade of neoplastic transformation by bromodomain and extra-terminal (BET) domain protein inhibitor JQ-1.
    Zhang C; Su ZY; Wang L; Shu L; Yang Y; Guo Y; Pung D; Bountra C; Kong AN
    Biochem Pharmacol; 2016 Oct; 117():35-45. PubMed ID: 27520485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BET Bromodomain Inhibitors Suppress Inflammatory Activation of Gingival Fibroblasts and Epithelial Cells From Periodontitis Patients.
    Maksylewicz A; Bysiek A; Lagosz KB; Macina JM; Kantorowicz M; Bereta G; Sochalska M; Gawron K; Chomyszyn-Gajewska M; Potempa J; Grabiec AM
    Front Immunol; 2019; 10():933. PubMed ID: 31114581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BET-inhibition by JQ1 alleviates streptozotocin-induced diabetic cardiomyopathy.
    Guo M; Wang HX; Chen WJ
    Toxicol Appl Pharmacol; 2018 Aug; 352():9-18. PubMed ID: 29782963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromodomains: Structure, function and pharmacology of inhibition.
    Ferri E; Petosa C; McKenna CE
    Biochem Pharmacol; 2016 Apr; 106():1-18. PubMed ID: 26707800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects.
    Shahbazi J; Liu PY; Atmadibrata B; Bradner JE; Marshall GM; Lock RB; Liu T
    Clin Cancer Res; 2016 May; 22(10):2534-44. PubMed ID: 26733615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma.
    Sengupta D; Kannan A; Kern M; Moreno MA; Vural E; Stack B; Suen JY; Tackett AJ; Gao L
    Epigenetics; 2015; 10(6):460-6. PubMed ID: 25941994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis.
    Krämer M; Dees C; Huang J; Schlottmann I; Palumbo-Zerr K; Zerr P; Gelse K; Beyer C; Distler A; Marquez VE; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2013 Apr; 72(4):614-20. PubMed ID: 22915621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylation of CCAR2 Establishes a BET/BRD9 Acetyl Switch in Response to Combined Deacetylase and Bromodomain Inhibition.
    Rajendran P; Johnson G; Li L; Chen YS; Dashwood M; Nguyen N; Ulusan A; Ertem F; Zhang M; Li J; Sun D; Huang Y; Wang S; Leung HC; Lieberman D; Beaver L; Ho E; Bedford M; Chang K; Vilar E; Dashwood R
    Cancer Res; 2019 Mar; 79(5):918-927. PubMed ID: 30643017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diacylglycerol Kinase Alpha in Radiation-Induced Fibrosis: Potential as a Predictive Marker or Therapeutic Target.
    Liu CS; Schmezer P; Popanda O
    Front Oncol; 2020; 10():737. PubMed ID: 32477950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis.
    Huber LC; Distler JH; Moritz F; Hemmatazad H; Hauser T; Michel BA; Gay RE; Matucci-Cerinic M; Gay S; Distler O; Jüngel A
    Arthritis Rheum; 2007 Aug; 56(8):2755-64. PubMed ID: 17665426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
    Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
    Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Bromodomain and Extraterminal Domain (BET) Proteins by JQ1 Unravels a Novel Epigenetic Modulation to Control Lipid Homeostasis.
    Tonini C; Colardo M; Colella B; Di Bartolomeo S; Berardinelli F; Caretti G; Pallottini V; Segatto M
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.